Vitrous Analysis in Proliferative Diabetic Retinopathy

ID: NCT01478763
Status: Completed
Phase: N/A
Start Date: January 01, 2011
First Submitted: November 21, 2011
Last Updated: September 24, 2014
Results: N/A
Organization: St. Erik Eye Hospital
Sponsors & Collaborators: Anders Kvanta
Location: Sweden
Conditions: Proliferative Diabetic Retinopathy
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Study Description

Brief Summary

Analysis of vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy

Detailed Description

To analyse and compare vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy.
Condition or disease Intervention/treatment Phase

Proliferative Diabetic Retinopathy

N/A

Tracking Information

First Submitted DateNovember 21, 2011
Last Update Posted DateSeptember 24, 2014
Start DateJanuary 01, 2011
Actual Completion DateSeptember 01, 2014
Primary Completion DateSeptember 01, 2014
Results First Submitted DateN/A
Received Results Disposit DateN/A

Current Primary Outcome Measures

Not Available

Original Primary Outcome Measures

Not Available

Current Secondary Outcome Measures

Not Available

Original Secondary Outcome Measures

Not Available

Study Design

Brief TitleVitrous Analysis in Proliferative Diabetic Retinopathy
Official TitleAnalysis of Vitreous Proteins in Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
Brief Summary

Analysis of vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy

Detailed Description

To analyse and compare vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy.

Study TypeObservational
Study PhaseN/A
Estimated Enrollment
200
Allocation
Not Available
Interventional Model
Not Available
Masking
Not Available
Primary Purpose
Not Available
Conditions
Proliferative Diabetic Retinopathy
Target Follow-Up Duration N/A
Biospecimen:
Retention: Samples With DNA
Description: Vitreous samples
Sampling MethodProbability Sample
Study PopulationPatients undergoing pars plana vitrectomy for proliferative diabetic retinopathy
Intervention
Not Available
Study Groups/Cohorts
Not Available
Study Arms
Not Available
Arm Intervention/Treatment

Recruitment Information

Recruitment Status:Completed
Enrollment200
Completion DateSeptember 01, 2014
Eligibility Criteria: Inclusion Criteria:
- proliferative diabetic retinopathy with vitreous hemorrhage

Exclusion Criteria:
- vitreous hemorrhage of other cause than proliferative diabetic retinopathy
- previous vitrectomy
GenderAll
Age12 Years to N/A
Accepts Healthy VolunteersNo
Contacts
Not Available
Listed Location Countries
Sweden

Administrative Information

NCT Number:NCT01478763
Other Study ID Numbers
Vitreous1
Has Data Monitoring CommitteeNo
U.S. FDA-regulated Product Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Device Product Not Approved or Cleared by U.S. FDA: No
IPD Sharing Statement
Not Available
Responsible PartyAnders Kvanta, St. Erik Eye Hospital
Study Sponsor
Anders Kvanta
Collaborators
Not Available
Investigators
Principal Investigator
Anders Kvanta, PhD
St. Erik Eye Hospital